Cataldo Bianco
About
Cataldo Bianco is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Cataldo Bianco has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cataldo Bianco's work include HER2/EGFR in Cancer Research (8 papers), Lung Cancer Treatments and Mutations (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Cataldo Bianco is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Lung Cancer Treatments and Mutations (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Cataldo Bianco collaborates with scholars based in Italy, United States and India. Cataldo Bianco's co-authors include Fortunato Ciardiello, Giampaolo Tortora, Roberto Bianco, David Raben, Gabriella Fontanini, Vincenzo Damiano, A R Bianco, Sabino De Placido, Angelo Raffaele Bianco and Stefano Pepe and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and Clinical Cancer Research.
In The Last Decade
Cataldo Bianco
37 papers receiving 1.4k citations
Peers
Cataldo Bianco
Lars Damstrup Denmark
Todd R. Palmby United States
Yasir H. Ibrahim United States
Marianna Gallo Italy
Dean B. Reardon United States
Brenda J Curry United Kingdom
Toshimitsu Uenaka Japan
Dana T. Aftab United States
Roberta Caputo Italy
Shailaja Kalyankrishna United States
Citations per year, relative to Cataldo Bianco Cataldo Bianco (= 1×)
peers
Lars Damstrup
Countries citing papers authored by Cataldo Bianco
Since
Specialization
Citations
This map shows the geographic impact of Cataldo Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cataldo Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cataldo Bianco more than expected).
Fields of papers citing papers by Cataldo Bianco
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Cataldo Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cataldo Bianco. The network helps show where Cataldo Bianco may publish in the future.
Co-authorship network of co-authors of Cataldo Bianco
This figure shows the co-authorship network connecting the top 25 collaborators of Cataldo Bianco. A scholar is included among the top collaborators of Cataldo Bianco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cataldo Bianco. Cataldo Bianco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Formisano, Luigi, Fabiana Napolitano, Roberta Rosa, et al.. (2020). Mechanisms of resistance to mTOR inhibitors. Critical Reviews in Oncology/Hematology. 147. 102886–102886.
2.
Dattilo, Vincenzo, Ferdinando Calabria, Lucia D’Antona, et al.. (2017). The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells. Cellular Physiology and Biochemistry. 43(1). 108–119.
3.
Marciano, Roberta, Alberto Servetto, Cataldo Bianco, & Roberto Bianco. (2017). Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report. Journal of Medical Case Reports. 11(1). 273–273.
4.
Dattilo, Vincenzo, Lucia D’Antona, Mjriam Capula, et al.. (2017). SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation. Scientific Reports. 7(1). 45361–45361.
5.
Dattilo, Vincenzo, Lucia D’Antona, Miranda Menniti, et al.. (2016). SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition. Cellular Physiology and Biochemistry. 39(5). 1863–1876.
6.
Ortuso, Francesco, Rosario Amato, Anna Artese, et al.. (2014). In Silico Identification and Biological Evaluation of Novel Selective Serum/Glucocorticoid-Inducible Kinase 1 Inhibitors Based on the Pyrazolo-Pyrimidine Scaffold. Journal of Chemical Information and Modeling. 54(7). 1828–1832.
7.
Marvaso, Giulia, et al.. (2014). The Current Status of Novel PET Radio-Pharmaceuticals in Radiotherapy Treatment Planning of Glioma. Current Pharmaceutical Biotechnology. 14(13). 1099–1104.
8.
Marvaso, Giulia, Nicola Amodio, Lavinia Raimondi, et al.. (2014). Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro. Cancer Biology & Therapy. 15(6). 797–805.
9.
Marvaso, Giulia, et al.. (2013). Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature. Oncology Letters. 6(4). 897–900.
10.
Bianco, Cataldo, Elisa Giovannetti, Fortunato Ciardiello, et al.. (2006). Synergistic Antitumor Activity of ZD6474, An Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, with Gemcitabine and Ionizing Radiation against Pancreatic Cancer. Clinical Cancer Research. 12(23). 7099–7107.
11.
Frederick, Barbara, et al.. (2005). ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 64(1). 33–37.
12.
Raben, David, Cataldo Bianco, Luka Milas, & K. Kian Ang. (2004). Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?. Seminars in Radiation Oncology. 14(2). 139–152.
13.
Raben, David, Cataldo Bianco, Vincenzo Damiano, et al.. (2004). Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. Molecular Cancer Therapeutics. 3(8). 977–983.
14.
Raben, David, et al.. (2002). Interference with EGFR signaling: paradigm for improving radiation response in cancer treatment. Expert Review of Anticancer Therapy. 2(4). 461–471.
15.
Ciardiello, Fortunato, V. Damiano, Cataldo Bianco, et al.. (1996). Antitumor Activity of Combined Blockade of Epidermal Growth Factor Receptor and Protein Kinase A. JNCI Journal of the National Cancer Institute. 88(23). 1770–1776.
16.
Placido, Sabino De, Francesco Nuzzo, Francesco Perrone, et al.. (1995). The First Breast Cancer Screening Program in Southern Italy: Preliminary Results from Three Municipalities of the Naples Province. Tumori Journal. 81(1). 7–12.
17.
North, Phillip, S L Davies, Fortunato Ciardiello, et al.. (1994). Overexpression of the RI alpha subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3'5'-monophosphate in Chinese hamster ovary cells.. PubMed. 54(15). 4123–8.
18.
Ciardiello, Fortunato, Stefano Pepe, Caterina Bianco, et al.. (1993). Down‐regulation of riα subunit of camp‐dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c‐ha‐ras and c‐erbb‐2 proto‐oncogenes. International Journal of Cancer. 53(3). 438–443.
19.
Ciardiello, Fortunato, Giampaolo Tortora, Stefano Pepe, et al.. (1993). Reduction of RIα Subunit of cAMP‐dependent Protein Kinase Expression Induces Growth Inhibition of Human Mammary Epithelial Cells Transformed by TGF‐α, c‐Ha‐ras, and c‐erbB‐2 Genes. Annals of the New York Academy of Sciences. 698(1). 102–107.
20.
Ciardiello, Fortunato, Daniel S. Liscia, Cataldo Bianco, et al.. (1989). mRNA Expression of Transforming Growth Factor Alpha in Human Breast Carcinomas and Its Activity in Effusions of Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 81(15). 1165–1171.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lars Damstrup Breakdown of academic impact, for papers by Todd R. Palmby Breakdown of academic impact, for papers by Yasir H. Ibrahim Breakdown of academic impact, for papers by Marianna Gallo Breakdown of academic impact, for papers by Dean B. Reardon Breakdown of academic impact, for papers by Brenda J Curry Breakdown of academic impact, for papers by Toshimitsu Uenaka Breakdown of academic impact, for papers by Dana T. Aftab Breakdown of academic impact, for papers by Roberta Caputo Breakdown of academic impact, for papers by Shailaja Kalyankrishna